The Phenotropil Treatment Of The Consequences Of Brain Organic Lesions
| Effect | Decrease |
| Trial Design | Cohort |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 99 |
| Gender | Both Genders |
| Age Range | 45-64 |
In persons with encephalopathy following gliomas or acute
lesions (of organic origin) given 200mg phenylpiracetam once daily noted improvements in depression (38+/-4%), anxiety (50+/-5%), and cognitive decline as assessed by the MMSE (45+/-6%) when compared to baseline. No control group was used in this open-label study.